alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest studies

Every summary in our library, newest first, as a dated timeline.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 24,451–24,475 of 27,380 studies, newest first · page 979 of 1096.

June 2003 23

  1. 2003-06-23

    Autobiographical memory and autonoetic consciousness: triple dissociation in neurodegenerative diseases

    ✓ Peer-reviewed Lewy body dementia Brain

    Key finding: An alternative model, the multiple trace theory (MTT), suggests that the capacity of the MTL to recollect episodic memories is of a more permanent nature. +1 more finding

    Full summary, score breakdown and related studies → Original source

  2. 2003-06-16

    Genetics of early-onset Alzheimer dementia

    ✓ Peer-reviewed Risk genes beyond APOE TheScientificWorldJournal

    Key finding: PSEN1 is the most frequently mutated EOAD gene with a mutation frequency of 18 to 50% in autosomal dominant EOAD. +4 more findings

    Full summary, score breakdown and related studies → Original source

  3. 2003-06-01

    The Effect of Education on Cognitive Performances and Its Implication for the Constitution of the Cognitive Reserve

    ✓ Peer-reviewed Disparities Developmental Neuropsychology

    Key finding: Some studies have suggested that people with a high educational level have a lower risk of developing dementia compared to people with a low educational level. +3 more findings

    Full summary, score breakdown and related studies → Original source

  4. 2003-06-01

    Description of Parkinson's disease as a clinical syndrome

    ✓ Peer-reviewed Risk factors Annals of the New York Academy of Sciences

    Key finding: Most cases are sporadic, of unknown etiology; but rare cases of monogenic mutations (10 genes at present count) show that there are multiple causes for the neuronal degeneration. +4 more findings

    Full summary, score breakdown and related studies → Original source

  5. 2003-06-01

    Plants used in Chinese and Indian traditional medicine for improvement of memory and cognitive function

    ✓ Peer-reviewed Treatments Pharmacology, biochemistry, and behavior

    Key finding: Some anticholinesterase (anti-ChE) alkaloids isolated from plants have been investigated for their potential in the treatment of AD, and are now in clinical use. +4 more findings

    Full summary, score breakdown and related studies → Original source

  6. 2003-06-01

    Glucagon-like peptide-1 decreases endogenous amyloid-beta peptide (Abeta) levels and protects hippocampal neurons from death induced by Abeta and iron

    ✓ Peer-reviewed Drug development Journal of neuroscience research

    Key finding: Collectively, these data suggest that GLP-1 can modify APP processing and protect against oxidative injury, two actions that suggest a novel therapeutic target for intervention in Alzheimer's disease.

    Full summary, score breakdown and related studies → Original source

  7. 2003-06-01

    Proteomic identification of nitrated proteins in Alzheimer's disease brain

    ✓ Peer-reviewed Genetics Journal of neurochemistry

    Key finding: Nitration of tyrosine in biological conditions represents a pathological event that is associated with several neurodegenerative diseases, such as amyotrophic lateral sclerosis, Parkinson's disease and Alzheimer's disease (AD). +1 more finding

    Full summary, score breakdown and related studies → Original source

  8. 2003-06-01

    Advance care planning in nursing homes: correlates of capacity and possession of advance directives

    ✓ Peer-reviewed End-of-life care The Gerontologist

    Key finding: Capacity assessments revealed that most residents could state a simple treatment preference (82.4%), but a sizable number did not retain capacity to understand treatment alternatives or appreciate the consequences of their choice.

    Full summary, score breakdown and related studies → Original source

  9. 2003-06-01

    The prognostic significance of subsyndromal delirium in elderly medical inpatients

    ✓ Peer-reviewed Clinical safety Journal of the American Geriatrics Society

    Key finding: SSD in elderly medical inpatients appears to be a clinically important syndrome that falls on a continuum between no symptoms and DSM-defined delirium. +1 more finding

    Full summary, score breakdown and related studies → Original source

  10. 2003-06-01

    Causative and susceptibility genes for Alzheimer's disease: a review

    ✓ Peer-reviewed Brain tissue and pathology Brain research bulletin

    Key finding: Three genes have been identified as responsible for the rare early-onset familial form of the disease: the amyloid precursor protein (APP) gene, the presenilin 1 (PSEN1) gene and the presenilin 2 (PSEN2) gene. +3 more findings

    Full summary, score breakdown and related studies → Original source

  11. 2003-06-01

    Screening for late life depression: cut-off scores for the Geriatric Depression Scale and the Cornell Scale for Depression in Dementia among Japanese subjects

    ✓ Peer-reviewed Brain tissue and pathology International journal of geriatric psychiatry

    Key finding: Proper screening of depression among older adults depends on accurate cut-off scores. +3 more findings

    Full summary, score breakdown and related studies → Original source

  12. 2003-06-01

    Longitudinal outcome of Parkinson's disease patients with psychosis

    ✓ Peer-reviewed Cognitive tests and assessment Neurology

    Key finding: Baseline data available from 59 patients enrolled in the PSYCLOPS (PSychosis and CLOzapine in PD Study) trial included age, age at onset of PD, duration of PD and psychosis, character of psychosis, medications, living setting, and scores for Mini-Mental State Examination (MMSE), Unified Parkinson's Disease Rating Scale, Hoehn and Yahr Scale, and Clinical Global Impression Scale. +3 more findings

    Full summary, score breakdown and related studies → Original source

  13. 2003-06-01

    TREMs in the immune system and beyond

    ✓ Peer-reviewed TREM2 and immune genetics Nature reviews. Immunology

    Key finding: TREM1 and TREM2 activate myeloid cells by signalling through the adaptor protein DAP12. +3 more findings

    Full summary, score breakdown and related studies → Original source

  14. 2003-06-01

    Truncated beta-amyloid peptide species in pre-clinical Alzheimer's disease as new targets for the vaccination approach

    ✓ Peer-reviewed Risk genes beyond APOE Journal of neurochemistry

    Key finding: For human beings, the efficiency of this therapeutic strategy has to take into account the specificities of human amyloid, especially at the early stages of 'sporadic' Alzheimer's disease (AD). +3 more findings

    Full summary, score breakdown and related studies → Original source

  15. 2003-06-01

    The 129 codon polymorphism of the prion protein gene influences earlier cognitive performance in Down syndrome subjects

    ✓ Peer-reviewed Down syndrome and Alzheimer's Journal of neurology

    Key finding: Recently, a frequent prion protein gene (PRNP) polymorphism consisting of a methionine (M) for valine (V) substitution at codon 129 has been associated with cognitive impairment in elderly individuals. +3 more findings

    Full summary, score breakdown and related studies → Original source

  16. 2003-06-01

    Leisure activities and the risk of dementia in the elderly

    ✓ Peer-reviewed How common it is The New England journal of medicine

    Key finding: Participation in leisure activities is associated with a reduced risk of dementia, even after adjustment for base-line cognitive status and after the exclusion of subjects with possible preclinical dementia. +4 more findings

    Full summary, score breakdown and related studies → Original source

  17. 2003-06-01

    Efficacy of donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer's disease and the effect on caregiver burden

    ✓ Peer-reviewed Treatments Journal of the American Geriatrics Society

    Key finding: The ADL benefits in AD patients treated with donepezil were associated with less caregiving time and lower levels of caregiver stress. +1 more finding

    Full summary, score breakdown and related studies → Original source

  18. 2003-06-01

    Salvia for dementia therapy: review of pharmacological activity and pilot tolerability clinical trial

    ✓ Peer-reviewed Caregiving Pharmacology, biochemistry, and behavior

    Key finding: (Spanish sage) extracts and constituents have demonstrated anticholinesterase, antioxidant, anti-inflammatory, oestrogenic and CNS depressant (sedative) effects all of which are currently relevant to the treatment of Alzheimer's disease (AD). +3 more findings

    Full summary, score breakdown and related studies → Original source

  19. 2003-06-01

    Differences between caregivers and noncaregivers in psychological health and physical health: a meta-analysis

    ✓ Peer-reviewed Caregiving Psychology and aging

    Key finding: Differences in the levels of physical health in favor of noncaregivers were statistically significant, but small (g = .18).

    Full summary, score breakdown and related studies → Original source

  20. 2003-06-01

    Screening for dementia in primary care: a summary of the evidence for the U.S. Preventive Services Task Force

    ✓ Peer-reviewed Treatments Annals of internal medicine

    Key finding: Study selection The authors developed eight key questions representing a logical chain between screening and improved health outcomes, along with eligibility criteria for admissible evidence for each question. +4 more findings

    Full summary, score breakdown and related studies → Original source

  21. 2003-06-01

    Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial

    ✓ Peer-reviewed Treatments JAMA

    Key finding: The results of this study indicate that rofecoxib or low-dose naproxen does not slow cognitive decline in patients with mild-to-moderate AD. +4 more findings

    Full summary, score breakdown and related studies → Original source

  22. 2003-06-01

    Increased risk of late posttraumatic seizures associated with inheritance of APOE epsilon4 allele

    ✓ Peer-reviewed Genetics Archives of neurology

    Key finding: Inheritance of the APOE epsilon4 allele is associated with increased risk of late posttraumatic seizures. +4 more findings

    Full summary, score breakdown and related studies → Original source

  23. 2003-06 month only

    Differences Between Caregivers and Noncaregivers in Psychological Health and Physical Health: A Meta-Analysis

    ✓ Peer-reviewed Caregiving Psychology and Aging

    Key finding: Caregivers showed higher depression (effect size g=0.58), higher stress (g=0.55), lower self-efficacy (g=0.54), and lower general well-being (g=-0.40) than non-caregivers +2 more findings

    Full summary, score breakdown and related studies → Original source

May 2003 2

  1. 2003-05-27

    Idebenone treatment in Friedreich patients: One-year-long randomized placebo-controlled trial

    ✓ Peer-reviewed Biomarkers Neurology

    Key finding: Whereas endogenous tau was not detected in astrocytes of control mice, in GFAP/tau Tg mice there was robust astrocytic tau expression that was associated with a redistribution of the GFAP network.

    Full summary, score breakdown and related studies → Original source

  2. 2003-05-23

    Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study

    ✓ Peer-reviewed Mild cognitive impairment European journal of nuclear medicine and molecular imaging

    Key finding: Compared with the healthy control group, a reduced rCMRglc in AD-typical regions, including the temporoparietal and posterior cingulate cortex, was detected at baseline in patients with MCI(AD). +2 more findings

    Full summary, score breakdown and related studies → Original source

Browse the library by subject, with the full score breakdown →